A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
about
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).
P2860
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A randomized clinical trial co ...... prophylaxis for HIV infection.
@en
A randomized clinical trial co ...... prophylaxis for HIV infection.
@nl
type
label
A randomized clinical trial co ...... prophylaxis for HIV infection.
@en
A randomized clinical trial co ...... prophylaxis for HIV infection.
@nl
prefLabel
A randomized clinical trial co ...... prophylaxis for HIV infection.
@en
A randomized clinical trial co ...... prophylaxis for HIV infection.
@nl
P2093
P2860
P356
P1476
A randomized clinical trial co ...... prophylaxis for HIV infection.
@en
P2093
Alexy Inciarte
Ana González-Cordón
Berta Torres
Christian Manzardo
Constanza Lucero
Jhon Rojas
Joan A Arnaiz
Josep M Gatell
Josep Mallolas
Judit Pich
P2860
P304
P356
10.1093/JAC/DKW048
P407
P577
2016-03-18T00:00:00Z